A. Waldmann

A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

W. Wels, F. Rödel, T. Klingebiel, 2017, Front. Immunol..

Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth

W. Wels, R. Marschalek, P. Bader, 2019, International journal of cancer.

Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity

W. Wels, N. Müller, Congcong Zhang, 2021, Journal for ImmunoTherapy of Cancer.

Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy

L. Trümper, M. Dreyling, M. Freund, 2007, Annals of Hematology.

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

W. Wels, T. Tonn, Congcong Zhang, 2017, Front. Immunol..

Immune Imbalance in Nasal Polyps of Caucasian Chronic Rhinosinusitis Patients Is Associated with a Downregulation of E-Selectin

B. Wollenberg, K. Bruchhage, R. Böscke, 2014, Journal of immunology research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Safety , efficacy , and pharmacokinetics / pharmacodynamics of daclizumab ( anti-CD 25 ) in patients with adult T-cell leukemia / lymphoma

Thomas, Urquhart, E. Jaffe, 2015 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.